Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K, filed on November 3, 2009, reports the third-quarter results for the period ending September 30, 2009. The filing serves to distribute an Investor News release (Exhibit 99.1) to U.S. investors. The registrant is a German partnership limited by shares.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It explicitly states that these figures are contained within the attached Investor News (Exhibit 99.1). The Company utilizes non-GAAP financial measures, specifically EBITDA (operating income excluding interest, taxes, depreciation, and amortization) and free cash flow, to supplement GAAP results.
Material Changes
The filing text does not detail specific material changes or year-over-year comparisons. It notes that the attached Investor News contains the consolidated financial results and reconciliations between non-GAAP and GAAP measures.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer regarding non-GAAP measures, stating they should not be used as a substitute for GAAP measures. It asserts that these measures are provided to enhance understanding of current performance and future prospects. No specific forward-looking guidance, risk factors, or contingencies are detailed in the cover text of this Form 6-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific Q3 2009 revenue, EBITDA, and free cash flow figures.
- Verify the reconciliation of non-GAAP measures to GAAP financial measures as referenced in the filing.
- Confirm the impact of the "Acting Chief Financial Officer" status on financial reporting continuity.
- Check for any specific operational updates or segment performance details contained only in the attached exhibit.